News Briefs

Walgreens Boots Alliance Inc. will spend $970 million to acquire a 71% stake in Shields Health Solutions, a specialty pharmacy company. Shields contracts with health systems and hospitals to build and operate on-site specialty pharmacies. The transaction builds on a minority investment that Walgreens made in July 2019. According to a Sept. 21 press release, Shields “represent[s] more than 1 million specialty patients across more than 30 disease states, with more than 70 health system partners nationwide.”

Inovalon Holdings Inc. struck a deal with CorEvitas LLC to gain access to CorEvitas’ analytics on rheumatoid arthritis and psoriasis. Inovalon will combine the data from the CorEvitas platform with its larger chronic condition database. According to a Sept. 21 press release on the deal, “insights made possible through these analytics can advance clinical development, inform trial design and recruitment, substantiate value narratives, and inform patient-specific intervention plans.”

© 2022 MMIT
AIS Health Staff

AIS Health Staff

Related Posts

pills
September 22

Report Shows Limited Access to Opioid Use Disorder Treatments for Medicare Beneficiaries

READ MORE
cms-website
September 22

Drug Price Negotiation Will Require New CMS Regulations, Staffing

READ MORE
fda-sign
September 22

Accelerated Approval Prices Are Unrelated to Clinical Value, Study Says

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today